EVALUATION OF MISOPROSTOL CYTOPROTECTION OF THE BLADDER WITH CYCLOPHOSPHAMIDE (CYTOXAN) THERAPY

被引:110
作者
GRAY, KJ [1 ]
ENGELMANN, UH [1 ]
JOHNSON, EH [1 ]
FISHMAN, IJ [1 ]
机构
[1] BAYLOR COLL MED,DEPT PATHOL,DIV PLAST SURG,MICROSURG LAB,HOUSTON,TX 77030
关键词
D O I
10.1016/S0022-5347(17)44929-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:497 / 500
页数:4
相关论文
共 22 条
[1]  
BAUER RS, COMMUNICATION
[2]   EXPERIENCE WITH MESNA IN PATIENTS RECEIVING ALLOGENEIC BONE-MARROW TRANSPLANTS FOR POOR PROGNOSTIC LEUKEMIA [J].
BLACKLOCK, H ;
BALL, L ;
KNIGHT, C ;
SCHEY, S ;
PRENTICE, G .
CANCER TREATMENT REVIEWS, 1983, 10 :45-52
[3]   PROSTAGLANDINS AND CHRONIC INFLAMMATION [J].
BONTA, IL ;
PARNHAM, MJ .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (12) :1611-1623
[4]   ACETYLCYSTEINE IN PREVENTION OF CYCLOPHOSPHAMIDE-INDUCED CYSTITIS IN RATS [J].
BOTTA, JA ;
NELSON, LW ;
WEIKEL, JH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1973, 51 (03) :1051-1058
[5]   THE DEVELOPMENT OF MESNA FOR REGIONAL DETOXIFICATION [J].
BROCK, N ;
POHL, J .
CANCER TREATMENT REVIEWS, 1983, 10 :33-&
[6]   STUDIES ON THE UROTOXICITY OF OXAZAPHOSPHORINE CYTOSTATICS AND ITS PREVENTION .2. COMPARATIVE-STUDY ON THE UROPROTECTIVE EFFICACY OF THIOLS AND OTHER SULFUR-COMPOUNDS [J].
BROCK, N ;
POHL, J ;
STEKAR, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (11) :1155-1163
[7]   CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT [J].
COX, PJ .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) :2045-2049
[8]   PREVENTION OF CYCLOPHOSPHAMIDE-INDUCED HEMORRHAGIC CYSTITIS [J].
DROLLER, MJ ;
SARAL, R ;
SANTOS, G .
UROLOGY, 1982, 20 (03) :256-258
[9]   URINARY-BLADDER COMPLICATIONS WITH CYCLOPHOSPHAMIDE THERAPY [J].
FOAD, BSI ;
HESS, EV .
ARCHIVES OF INTERNAL MEDICINE, 1976, 136 (05) :616-619
[10]  
GUTH PH, 1983, DIG DIS SCI, V28